Chris Mason MD, PhD, FRCS
Biotechnology, Molecular Biology
Cambridge, Massachusetts, United States of America
Connect with the speaker?
Chris is a clinician-scientist with over 20 years of cell and gene therapy experience including Full Professor of Regenerative Medicine Bioprocessing at University College London. He has a multidisciplinary track record spanning R&D, clinical medicine, bioprocessing, regulation, healthcare economics, reimbursement and commercialization.
Chris is co-founder of the London Regenerative Medicine Network, trustee of the UK Stem Cell Foundation and on the UK-Israel Science Council. Current SAB appointments include; public and private companies, the UK Cell Therapy Catapult and the Canadian Center for the Commercialization of Regenerative Medicine. Chris is Senior Editor of the journals ‘Cell and Gene Therapy Insights’ and ‘Regenerative Medicine’.
Chris is co-founder of the London Regenerative Medicine Network, trustee of the UK Stem Cell Foundation and on the UK-Israel Science Council. Current SAB appointments include; public and private companies, the UK Cell Therapy Catapult and the Canadian Center for the Commercialization of Regenerative Medicine. Chris is Senior Editor of the journals ‘Cell and Gene Therapy Insights’ and ‘Regenerative Medicine’.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)
Cell & Gene Therapy World
In-Person Event
Biotechnology ...
Jan 22 - 25, 2018
Miami, Florida, USA
Cell and Gene Therapy Europe 2015
- In-Person Event
- Genetics ...
- Sep 29 - 30, 2015
- Barcelona, Cataluna, ES
Scale-Up and Manufacturing of Cell-Based Therapies IV
- In-Person Event
- Genetics
- Jan 18 - 22, 2015
- San Diego, California, USA
Quick Links
- 50 Division Street, Suite 501,
- Somerville, NJ 08876
- support@emedevents.com